GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clene Inc (NAS:CLNNW) » Definitions » Price-to-Funds-From-Operations

Clene (CLNNW) Price-to-Funds-From-Operations : (As of Jun. 08, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Clene Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Clene (CLNNW) Business Description

Industry
Traded in Other Exchanges
Address
6550 South Millrock Drive, Suite G50, Salt Lake City, UT, USA, 84121
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. Its reportable segments: (1) the development and commercialization of novel clean-surfaced nanotechnology therapeutics (Drugs, and (2) the development and commercialization of dietary supplements (Supplements).